{"id":"https://openalex.org/W3167401398","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.tps1104","title":"AMEERA-5: A randomized, double-blind phase III study of amcenestrant (SAR439859) + palbociclib versus letrozole + palbociclib for previously untreated ER+/HER2- advanced breast cancer.","display_name":"AMEERA-5: A randomized, double-blind phase III study of amcenestrant (SAR439859) + palbociclib versus letrozole + palbociclib for previously untreated ER+/HER2- advanced breast cancer.","publication_year":2021,"publication_date":"2021-05-20","ids":{"openalex":"https://openalex.org/W3167401398","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.tps1104","mag":"3167401398"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.15_suppl.tps1104","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.tps1104","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.tps1104","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier Cortes","raw_affiliation_strings":["International Breast Cancer Center (IBCC), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Breast Cancer Center (IBCC), Barcelona, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068059897","display_name":"Sara Alsterlind Hurvitz","orcid":"https://orcid.org/0000-0001-7808-7191","observed_orcids":["https://orcid.org/0000-0001-7808-7191"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara A. Hurvitz","raw_affiliation_strings":["UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083142899","display_name":"Suzette Delaloge","orcid":"https://orcid.org/0000-0003-2106-9165","observed_orcids":["https://orcid.org/0000-0003-2106-9165"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Suzette Delaloge","raw_affiliation_strings":["Institute Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008549101","display_name":"Hiroji Iwata","orcid":"https://orcid.org/0000-0002-0242-4718","observed_orcids":["https://orcid.org/0000-0002-0242-4718"]},"institutions":[{"id":"https://openalex.org/I4405286927","display_name":"Aichi Cancer Center Hospital","ror":"https://ror.org/03kh0z432","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroji Iwata","raw_affiliation_strings":["Aichi Cancer Center Hospital, Nagoya, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aichi Cancer Center Hospital, Nagoya, Japan;","institution_ids":["https://openalex.org/I4405286927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100744578","display_name":"Zhimin Shao","orcid":"https://orcid.org/0000-0002-4567-7635","observed_orcids":["https://orcid.org/0000-0002-4567-7635"]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shao Zhimin","raw_affiliation_strings":["Fudan University, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fudan University, Shanghai, China;","institution_ids":["https://openalex.org/I24943067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037865295","display_name":"Dheepak Kanagavel","orcid":"https://orcid.org/0000-0002-7684-8580","observed_orcids":["https://orcid.org/0000-0002-7684-8580"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dheepak Kanagavel","raw_affiliation_strings":["Sanofi, Vitry-Sur-Seine, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Vitry-Sur-Seine, France;","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004188539","display_name":"Patrick Cohen","orcid":"https://orcid.org/0009-0008-1187-1123","observed_orcids":["https://orcid.org/0009-0008-1187-1123"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrick Cohen","raw_affiliation_strings":["Sanofi, Vitry-Sur-Seine, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Vitry-Sur-Seine, France;","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073540330","display_name":"Qianying Liu","orcid":"https://orcid.org/0000-0003-0765-7243","observed_orcids":["https://orcid.org/0000-0003-0765-7243"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qianying Liu","raw_affiliation_strings":["Sanofi, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073655713","display_name":"Sylvaine Cartot\u2010Cotton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sylvaine Cartot-Cotton","raw_affiliation_strings":["Sanofi, Vitry-Sur-Seine, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Vitry-Sur-Seine, France;","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091087835","display_name":"Vasiliki Pelekanou","orcid":"https://orcid.org/0000-0002-8431-1927","observed_orcids":["https://orcid.org/0000-0002-8431-1927"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vasiliki Pelekanou","raw_affiliation_strings":["Sanofi, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Cambridge, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joyce O'Shaughnessy","raw_affiliation_strings":["Texas Oncology, Baylor-Sammons Cancer Center, US Oncology, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology, Baylor-Sammons Cancer Center, US Oncology, Dallas, TX;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"15_suppl","first_page":"TPS1104","last_page":"TPS1104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.8820000290870667},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9819999933242798},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.5989999771118164},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.921999990940094},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.45500001311302185},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7789999842643738},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8989999890327454},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.982125461101532},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.8771642446517944},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8454695343971252},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.8149920105934143},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5891659259796143},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5861936807632446},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5386303663253784},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5224001407623291},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.5155975222587585},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.462822288274765},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4617614150047302},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.41347992420196533},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36786866188049316},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.2773441672325134},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25464290380477905}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.15_suppl.tps1104","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.tps1104","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.tps1104","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220834601","https://openalex.org/W4220992037","https://openalex.org/W4221124594","https://openalex.org/W4220857846","https://openalex.org/W3203814516","https://openalex.org/W4220823416","https://openalex.org/W3167408526","https://openalex.org/W4399765251","https://openalex.org/W4281778952","https://openalex.org/W4286508883"],"abstract_inverted_index":{"TPS1104":[0],"Background:":[1],"Selective":[2],"estrogen":[3,8,277],"receptor":[4,9,47,278],"degraders":[5],"(SERDs)":[6],"block":[7],"(ER)":[10],"associated":[11],"signaling":[12],"and":[13,46,63,69,111,213,252,330,363,372,382],"have":[14,236],"created":[15],"interest":[16],"for":[17,34,152,156,171,191,242],"treating":[18],"patients":[19],"(pts)":[20],"with":[21,57,88,105,123,144,167,219,227,256,297,302],"advanced":[22,35,90,157,173,243],"ER+":[23],"breast":[24,158],"cancer":[25],"(BC).":[26],"Fulvestrant":[27],"is":[28,51,201,313,336],"currently":[29],"the":[30,42,80,149,211,270,325],"only":[31],"SERD":[32,54],"available":[33],"BC":[36,234],"but":[37,175],"requires":[38],"intramuscular":[39],"administration,":[40],"limiting":[41],"applied":[43],"dose,":[44],"exposure":[45],"engagement.":[48],"Amcenestrant":[49],"(SAR439859)":[50],"an":[52,145,202],"oral":[53],"that":[55,220],"binds":[56],"high":[58],"affinity":[59],"to":[60,72,285,316,370],"both":[61,300],"wild-type":[62],"mutant":[64],"ER,":[65],"blocking":[66],"estradiol":[67],"binding":[68],"promoting":[70],"up":[71],"98%":[73],"ER":[74,101],"degradation":[75],"in":[76,165,183,195,225,378],"preclinical":[77],"studies.":[78],"In":[79],"phase":[81,136,207],"I":[82,137],"AMEERA-1":[83],"study":[84,209,246],"of":[85,103,133,215,221,263,269,327,355,361,367,397],"pretreated":[86],"pts":[87,166,226],"ER+/HER2-":[89,172,233],"BC,":[91,174],"amcenestrant":[92,124,216,288,362],"150\u2013600":[93],"mg":[94,290,294,305],"once":[95],"daily":[96],"(QD)":[97],"showed":[98],"a":[99,112,188],"mean":[100],"occupancy":[102],"94%":[104],"plasma":[106],"concentrations":[107],">":[108],"100":[109],"ng/mL":[110],"favorable":[113],"safety":[114,214],"profile":[115],"(Bardia,":[116],"2019;":[117,409],"data":[118],"on":[119],"file).":[120],"Combination":[121],"therapy":[122,241,266],"+":[125,217,223],"palbociclib":[126],"(palbo)":[127],"was":[128],"also":[129],"evaluated":[130],"as":[131,396],"part":[132],"this":[134,196],"ongoing":[135],"study.":[138],"CDK":[139],"4/6":[140],"inhibitors":[141],"(CDK4/6i)":[142],"combined":[143,301],"aromatase":[146],"inhibitor":[147],"(AI),":[148],"gold":[150],"standard":[151],"first":[153],"line":[154],"treatment":[155,170],"cancer,":[159],"prolong":[160],"progression":[161,257,339],"free":[162,340,384],"survival":[163,341],"(PFS)":[164,342],"no":[168],"prior":[169,239],"OS":[176],"benefit":[177,358],"has":[178],"not":[179,237],"been":[180],"shown":[181],"yet":[182],"postmenopausal":[184],"pts.":[185,401],"There":[186],"remains":[187],"clinical":[189,357],"need":[190],"more":[192],"effective":[193],"treatments":[194],"setting.":[197],"Methods:":[198],"AMEERA-5":[199],"(NCT04478266)":[200],"ongoing,":[203],"prospective,":[204],"randomized,":[205],"double-blind":[206],"III":[208],"comparing":[210],"efficacy":[212],"palbo":[218,224,303],"letrozole":[222,292],"advanced,":[228],"locoregional":[229],"recurrent":[230,323],"or":[231,259,291],"metastatic":[232,321],"who":[235],"received":[238],"systemic":[240],"disease.":[244],"The":[245,333],"includes":[247],"men,":[248],"pre/peri-menopausal":[249],"(with":[250],"goserelin)":[251],"post-menopausal":[253],"women.":[254],"Pts":[255,281],"during":[258],"within":[260],"12":[261],"months":[262],"(neo)adjuvant":[264],"endocrine":[265],"using":[267],"any":[268],"following":[271],"agents":[272],"are":[273,282,347],"excluded:":[274],"AI,":[275],"selective":[276],"modulators,":[279],"CDK4/6i.":[280],"randomized":[283],"1:1":[284],"either":[286],"continuous":[287],"200":[289],"2.5":[293],"QD":[295,306],"orally":[296,307],"matching":[298],"placebos;":[299],"125":[304],"(d1\u201321":[308],"every":[309],"28-d":[310],"cycle).":[311],"Randomization":[312],"stratified":[314],"according":[315],"disease":[317],"type":[318],"(de":[319],"novo":[320],"vs":[322],"disease),":[324],"presence":[326],"visceral":[328],"metastasis,":[329],"menopausal":[331],"status.":[332],"primary":[334],"endpoint":[335],"investigator":[337],"assessed":[338],"(RECIST":[343],"v1.1).":[344],"Secondary":[345],"endpoints":[346],"overall":[348],"survival,":[349],"PFS2,":[350],"objective":[351],"response":[352],"rate,":[353,359],"duration":[354],"response,":[356],"pharmacokinetics":[360],"palbo,":[364],"health-related":[365],"quality":[366],"life,":[368],"time":[369],"chemotherapy,":[371],"safety.":[373],"Biomarkers":[374],"will":[375],"be":[376],"measured":[377],"paired":[379],"tumor":[380],"biopsies":[381],"cell":[383],"deoxyribonucleic":[385],"acid":[386],"(cfDNA)":[387],"over":[388],"time.":[389],"Target":[390],"enrolment":[391,395],"=":[392,399],"1066":[393],"pts;":[394],"1/2021":[398],"33":[400],"Bardia":[402],"A,":[403],"et":[404],"al.,":[405],"J":[406],"Clin":[407],"Oncol.":[408],"37":[410],"(15":[411],"suppl):1054":[412],"Clinical":[413],"trial":[414],"information:":[415],"NCT04478266":[416],".":[417]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2021-06-22T00:00:00"}